Marquis Who’s Who Honors Wilmin P. Bartolini for Expertise in Pharmaceutical Consulting
Wilmin P. Bartolini excels in clinical pharmacology and early clinical development as the owner of Pharma 42 LLC...Read More
Research
Kirikiri Customs Boosts Revenue by 61%, Hands Over Expired Drugs to NAFDAC
Kirikiri Customs Boosts Revenue by 61%, Hands Over Expired Drugs to NAFDAC The Kirikiri Lighter Terminal (KLT) Area Command of...
Scientists achieve record-breaking growth in miniature, functional liver models
While organoids aim to mimic human organs, the liver's repertoire of complex functions - and thus the energy it needs...
Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer's disease
A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular...
Pharma companies issue demands to stay in EU ahead of expected US tariffs as Irish economy braces itself
Nearly three dozen global pharmaceutical companies, in a letter to the head of the European Commission, demanded help to maintain...
Interview: Markus Schümmelfeder, CIO, Boehringer Ingelheim
The pharmaceutical giant has built a digital and data platform based on cloud and standardisation, from which it is exploring...
Potential treatment for Parkinson's using investigational cell therapy shows early promise
A stem cell-based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for...
Trump signs order aimed at lowering drug prices
President Trump signed a wide-ranging executive order Tuesday addressing drug costs that endorses a pharmaceutical industry-backed change to Medicare drug...
Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA
HONG KONG, Apr 15, 2025 - (ACN Newswire) - HighTide Therapeutics, Inc. (2511.HK), a clinical-stage biopharmaceutical company specializing in the...
Researchers develop an LSD analogue with potential for treating schizophrenia
University of California, Davis researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic...
US begins inquiry into pharmaceutical and chip imports in bid to impose tariffs
Notices show Trump administration setting stage for levies on both sectors on national security groundsThe Trump administration is kicking off...
US opens door to levies on microchips, pharmaceuticals; Trump hints at auto tariff pause
Tesla, other automaker stocks rise after White House comments...Read More
Donald Trump says he is ready to go to war with Xi Jinping’s China, are we seriously headed for World War III?
Donald Trump suggests tariffs are vital for US war preparedness. He hints at pharmaceutical tariffs to reduce reliance on China....
New ResolverRAT malware targets pharma and healthcare orgs worldwide
A new remote access trojan (RAT) called 'ResolverRAT' is being used against organizations globally, with the malware used in recent attacks...
The gut health benefits of sauerkraut
Is sauerkraut more than just a tangy topping? A new University of California, Davis, study published in Applied and Environmental...
Marquis Who’s Who Honors Mike Martin for Expertise in Market Research and Analytics
Mike Martin is a respected leader in the pharmaceutical sector and a dedicated advocate for the Muscular Dystrophy Association (MDA...Read...
Egyptian Drug Authority, Abbott discuss localizing pharmaceutical production
Chairperson of the Egyptian Drug Authority (EDA), Ali Ghamrawy, held an extensive meeting with representatives from global healthcare company Abbott...
FDA: Job cuts at US health agency raises concerns over drug approvals
The US FDA is coping with a series of Trump-imposed job cuts. These are starting to hamper food safety and...
Trump’s pharmaceutical tariffs could raise costs for patients, worsen drug shortages
It's unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is...
Potential Alzheimer's disease therapeutic target identified in brain immune cells
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its...
